With TheraTears, Prestige Consumer Sees Way To Boost Guidance Despite COVID, Cost Uncertainties

 
• By Malcolm Spicer
Prestige Consumer Healthcare starts its FY2022 with higher returns in sales, net income and EPS driven by higher spending on advertising/marketing and on costs of goods sold.

More from International

More from Geography